FDA 483 OBSERVATION · #263 OF 1,945 MOST-CITED

Prevention of the spread of communicable diseases

FDA cited this observation 113 times across 96 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.

BY PROGRAM AREA
Parts 1240 and 1250113
BY FISCAL YEAR
FY20271
FY202623
FY202525
FY202410
FY20232
FY20229
FY20211
FY20195
FY201815
FY20174
FY201618

What this observation is associated with

Firms cited for this observation also appear in FDA compliance actions — warning letters, injunctions, or seizures — at 0× the rate of the average FDA-cited firm (0.0% vs 7.8%), across 96 FEI-matched firms.

This is an association, not causation, and reflects co-occurrence in FDA's records — not a claim that the observation caused or preceded the action.

CHECKING ACCESS

Checking your access…

How FDA worded it — real examples

Servicing area are not operated as to prevent the spread of communicable diseases.

Million Air of Orlando · Sanford, Florida · Parts 1240 and 1250 · 2026-10-06

Servicing area are not provided with all necessary sanitary facilities, operated and maintained as to prevent the spread of communicable diseases.

Jet Blue Airways Corporation · Jamaica, New York · Parts 1240 and 1250 · 2026-08-18

Servicing area are not operated as to prevent the spread of communicable diseases.

American Airlines, Inc · Orlando, Florida · Parts 1240 and 1250 · 2026-07-23

Servicing area are not maintained as to prevent the spread of communicable diseases.

Charles M. Schulz Sonoma County Airport · Santa Rosa, California · Parts 1240 and 1250 · 2026-06-30

Servicing area are not provided with all necessary sanitary facilities, operated and maintained as to prevent the spread of communicable diseases.

Chicago Department of Aviation -Terminal 5 · Chicago, Illinois · Parts 1240 and 1250 · 2026-06-29

Servicing area are not operated and maintained as to prevent the spread of communicable diseases.

Circle Line Sightseeing Yachts Inc · New York, New York · Parts 1240 and 1250 · 2026-06-29

Examples are a representative sample of FDA's published inspection observations. Open the 483 observation explorer →